Progress in treatment of gliomas
- PMID: 39498845
- DOI: 10.1097/WCO.0000000000001324
Progress in treatment of gliomas
References
-
- Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol 2023; 25: (12 Suppl 2): iv1–iv99.
-
- McFaline-Figueroa JR, Wen PY. Negative trials over and over again: how can we do better? Neuro Oncol 2023; 25:1–3.
-
- Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23:1231–1251.
-
- Bouffet E, Hansford JR, Garre ML, et al. Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 2023; 389:1108–1120.
-
- Kilburn LB, Khuong-Quang DA, Hansford JR, et al. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. Nat Med 2024; 30:207–217.
LinkOut - more resources
Full Text Sources
